SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the September 2022 quarter is pegged at Rs. 771.77 millions, about 18.90% up against Rs. 649.11 millions recorded during the year-ago period.Net profit stood at Rs. 136.16  millions  compared to Rs. 128.40 millions in the corresponding previous quarter,high by 6.04%.Operating profit surged to 209.46 millions from the corresponding previous quarter of 195.43 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 771.77 649.11 18.90 1492.87 1376.63 8.44 2727.98 2834.73 -3.77
Other Income 20.00 19.02 5.15 32.45 28.45 14.06 90.80 68.23 33.08
PBIDT 209.46 195.43 7.18 336.59 469.05 -28.24 817.28 1075.34 -24.00
Interest 0.26 0.08 225.00 0.54 0.16 237.50 0.95 1.00 -5.00
PBDT 209.20 195.35 7.09 336.05 468.89 -28.33 816.33 1074.34 -24.02
Depreciation 25.07 22.91 9.43 49.16 45.59 7.83 95.61 90.06 6.16
PBT 184.13 172.44 6.78 286.89 423.30 -32.23 720.72 984.28 -26.78
TAX 47.97 44.04 8.92 72.95 109.42 -33.33 175.61 274.16 -35.95
Deferred Tax 0.77 -0.76 -201.32 -0.31 -0.52 -40.38 -4.56 25.72 -117.73
PAT 136.16 128.40 6.04 213.94 313.88 -31.84 545.11 710.12 -23.24
Equity 223.64 223.56 0.04 223.64 223.56 0.04 223.60 223.46 0.06
PBIDTM(%) 27.14 30.11 -9.86 22.55 34.07 -33.83 29.96 37.93 -21.02

Advanced Enzyme Share Price

298.60 -0.40 (-0.13%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×